Cutaneous Larva Migrans

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform

Hermann Feldmeier - One of the best experts on this subject based on the ideXlab platform.

Eric Caumes - One of the best experts on this subject based on the ideXlab platform.

  • molecular characterization of ancylostoma braziliense Larvae in a patient with hookworm related Cutaneous Larva Migrans
    American Journal of Tropical Medicine and Hygiene, 2012
    Co-Authors: Alexandre Le Joncour, Sandrine A Lacour, Gabriel Lecso, Stephanie Regnier, Jacques Guillot, Eric Caumes
    Abstract:

    We report a case of hookworm-related Cutaneous Larva Migrans diagnosed microscopically. Viable hookworm Larvae were found by microscopic examination of a skin scraping from follicular lesions. Amplification and sequencing of the internal transcribed spacer 2 allowed the specific identification of the Larvae as Ancylostoma braziliense.

  • hookworm related Cutaneous Larva Migrans
    Journal of Travel Medicine, 2007
    Co-Authors: Patrick Hochedez, Eric Caumes
    Abstract:

    Cutaneous Larva Migrans (CLM) is the most frequent travel‐associated skin disease of tropical origin. 1,2 This dermatosis first described as CLM by Lee in 1874 was later attributed to the subCutaneous migration of Ancylostoma Larvae by White and Dove in 1929. 3,4 Since then, this skin disease has also been called creeping eruption, creeping verminous dermatitis, sand worm eruption, or plumber’s itch, which adds to the confusion. It has been suggested to name this disease hookworm‐related Cutaneous Larva Migrans (HrCLM). 5 Although frequent, this tropical dermatosis is not sufficiently well known by Western physicians, and this can delay diagnosis and effective treatment. Indeed, misdiagnosis or inappropriate treatment affects 22% to 58% of the travelers with CLM. 6–8 In one case report, the time lag between the onset of disease and the diagnosis was 22 months. 9 Five large (>40 patients each) published studies of imported cases of CLM in returning travelers have greatly helped improve knowledge of this disease. 2,6–8,10 This is particularly true as regards its natural history and response to treatment in short‐term travelers without possibility of recontamination. We reviewed the epidemiological, clinical, and therapeutic data drawn from studies of CLM in travelers. The aim of this review was to contribute to a better definition and description of the disease known as HrCLM. HrCLM is one of the leading causes of dermatologic disorders observed in ill returned travelers. 1,2,11 Risk factors for developing HrCLM have specifically been investigated in one outbreak in Canadian tourists: less frequent use of protective footwear while walking on the beach was significantly associated with a higher risk of developing the disease, with a risk ratio of 4. Moreover, affected patients were somewhat younger than unaffected travelers (36.9 vs 41.2 yr, p = 0.014). There was no correlation between the reported amount of time … Corresponding Author: Eric Caumes, MD, Departement des Maladies Infectieuses et Tropicales, Hopital Pitie‐Salpetriere, 45‐83 Bld de l’hopital, F‐75013 Paris, France. E‐mail: eric.caumes{at}psl.aphp.fr

  • Treatment of Cutaneous Larva Migrans and Toxocara infection
    Fundamental & clinical pharmacology, 2003
    Co-Authors: Eric Caumes
    Abstract:

    The treatment of Cutaneous Larva Migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin. The efficacy of these agents varies according to the helminthic disease.

  • Cutaneous Larva Migrans with folliculitis report of seven cases and review of the literature
    British Journal of Dermatology, 2002
    Co-Authors: Eric Caumes, F Bricaire
    Abstract:

    Seven patients (four men, three women, mean age 31 years), all returning from the tropics, presented with pruritic folliculitis and creeping eruption. The folliculitis consisted of 20-100 follicular papules and pustules confined to a particular area of the body, mainly the buttocks. The creeping eruption consisted of two to 10 serpiginous or linear burrows 1-5 cm long located either in the same area or in a different area from the folliculitis. Five patients were cured with one to three courses of ivermectin (one course in two cases, two courses in two cases and three courses in one case) and two patients were cured with a 3-day regimen of albendazole. Folliculitis should be added to the dermatological manifestations of Cutaneous Larva Migrans. Treatment is more difficult than in classical forms of Cutaneous Larva Migrans.

  • treatment of Cutaneous Larva Migrans
    Clinical Infectious Diseases, 2000
    Co-Authors: Eric Caumes
    Abstract:

    Cutaneous Larva Migrans caused by the Larvae of animal hookworms is the most frequent skin disease among travelers returning from tropical countries. Complications (impetigo and allergic reactions), together with the intense pruritus and the significant duration of the disease, make treatment mandatory. Freezing the leading edge of the skin track rarely works. Topical treatment of the affected area with 10%-15% thiabendazole solution or ointment has limited value for multiple lesions and hookworm folliculitis, and requires applications 3 times a day for at least 15 days. Oral thiabendazole is poorly effective when given as a single dose (cure rate, 68%-84%) and is less well tolerated than either albendazole or ivermectin. Treatment with a single 400-mg oral dose of albendazole gives cure rates of 46%-100%; a single 12-mg oral dose of ivermectin gives cure rates of 81%-100%.

Angela Schuster - One of the best experts on this subject based on the ideXlab platform.

Hannah Lesshafft - One of the best experts on this subject based on the ideXlab platform.

Ralf Ignatius - One of the best experts on this subject based on the ideXlab platform.